Invention Grant
- Patent Title: Fused (hetero)cyclic compounds as S1P modulators
-
Application No.: US15388516Application Date: 2016-12-22
-
Publication No.: US10280159B2Publication Date: 2019-05-07
- Inventor: Wilhelm Amberg , Udo Lange , Herve Geneste , Michael Ochse , Ralf Biesinger , Frank Oellien
- Applicant: AbbVie Deutschland GmbH & Co. KG
- Applicant Address: DE Wiesbaden
- Assignee: ABBVIE DEUTSCHLAND GMBH & CO. KG
- Current Assignee: ABBVIE DEUTSCHLAND GMBH & CO. KG
- Current Assignee Address: DE Wiesbaden
- Agency: Neal, Gerber & Eisenberg LLP
- Main IPC: C07D413/12
- IPC: C07D413/12 ; C07D205/04 ; C07C229/48 ; C07C229/46 ; C07D211/62 ; C07D261/12 ; C07D209/52 ; C07D207/16 ; C07D207/08 ; C07D265/36 ; C07C59/72 ; C07D405/04 ; C07D311/04 ; C07D405/14 ; C07D311/58 ; C07C229/30 ; C07C229/36 ; C07C229/50 ; C07D207/06 ; C07D265/38 ; C07D209/94 ; C07D211/32
Abstract:
The invention relates to (hetero)cyclic compounds as S1P modulators, pharmaceutical compositions comprising such compounds, and uses thereof in the treatment, alleviation or prevention of diseases or disorders mediated by an S1P receptor.
Public/Granted literature
- US20170174672A1 FUSED (HETERO)CYCLIC COMPOUNDS AS S1P MODULATORS Public/Granted day:2017-06-22
Information query
